Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.
J Clin Aesthet Dermatol. 2015 Aug;8(8):29-35
Authors: Holmes AD, Waite KA, Chen MC, Palaniswamy K, Wiser TH, Draelos ZD, Rafal ES, Werschler WP, Harvey AE
Abstract
BACKGROUND: The topical
More...
NIH - Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in
J Clin Aesthet Dermatol. 2015 Aug;8(8):29-35
Authors: Holmes AD, Waite KA, Chen MC, Palaniswamy K, Wiser TH, Draelos ZD, Rafal ES, Werschler WP, Harvey AE
Abstract
BACKGROUND: The topical
More...
0 commentaires:
Enregistrer un commentaire